about
Genomic diversity in myeloproliferative neoplasms: focus on myelofibrosisSelective Janus associated kinase 1 inhibition as a therapeutic target in myelofibrosis.Sclt1 deficiency causes cystic kidney by activating ERK and STAT3 signaling.Obstructive Uropathy as an Initial Presentation of Primary Myelofibrosis: Case Report and Review of Literature.Identification of potential therapeutic target genes and miRNAs for primary myelofibrosis with microarray analysis.Imatinib and ruxolitinib association: first experience in two patients.Recombinant interferon-α in myelofibrosis reduces bone marrow fibrosis, improves its morphology and is associated with clinical response.P-Selectin Sustains Extramedullary Hematopoiesis in the Gata1 low Model of Myelofibrosis.
P2860
Q26770330-1594068B-EA17-47F4-9B60-E6DFDACF6076Q33419762-88E79D72-008D-4E90-BC3D-BFF84D478F5CQ38795694-02CB10ED-1E94-4CFE-97D4-237EAC3F6D4BQ38894833-9CE163BF-BC57-4025-991D-2C79D275C097Q41665045-5CD536B6-D0AA-45A4-A4B9-5CCE9B353540Q42609653-954CD511-EDEB-468D-9D6A-AA16F44A857EQ44993985-4CB96119-80FB-4EF8-892B-16C9D9840827Q52664220-9B745691-B1ED-4403-9A57-68EC03ACB984
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advances in myelofibrosis: a clinical case approach.
@en
Advances in myelofibrosis: a clinical case approach.
@nl
type
label
Advances in myelofibrosis: a clinical case approach.
@en
Advances in myelofibrosis: a clinical case approach.
@nl
prefLabel
Advances in myelofibrosis: a clinical case approach.
@en
Advances in myelofibrosis: a clinical case approach.
@nl
P2093
P2860
P1433
P1476
Advances in myelofibrosis: a clinical case approach.
@en
P2093
Attilio Orazi
Claire Harrison
John O Mascarenhas
Kapil N Bhalla
Richard E Champlin
Ronald Hoffman
P2860
P304
P356
10.3324/HAEMATOL.2013.086348
P577
2013-10-01T00:00:00Z